TG Therapeutics, Inc. (TGTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TGTX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 22,050,045 | $1.2B | DECREASED |
| State Street | 7,786,471 | $428M | DECREASED |
| Congress Asset Management | 2,600,123 | $143M | INCREASED |
| Pictet Asset Management Holding | 1,785,951 | $98M | INCREASED |
| BNY Mellon | 900,482 | $49M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Laurence N Charney (Director) | GIFT | 450 | 2026-08-06 | |
| Laurence N Charney (Director) | GIFT | 500 | 2026-08-06 | |
| Laurence N Charney (Director) | GIFT | 5,100 | 2026-08-06 | |
| Laurence N Charney (Director) | AWARD | 8,325 | 2026-06-11 | |
| Yann Echelard (Director) | AWARD | 8,325 | 2026-06-11 |
Full institutional holdings, insider history, and congressional trades for TG Therapeutics, Inc. on SentiSense.